Serum levels of adipocyte fatty acid-binding protein are independently associated with left ventricular mass and myocardial performance index in obstructive sleep apnea syndrome

Journal of Investigative Medicine

Volumn 60, Issue 7, 2012, Pages 1020-1026

  Balci, Mustafa Mücahit ^a   Arslan, Uǧur ^b   Firat, Hikmet ^c   Kocaoǧlu, Ibrahim ^a   Vural, Mustafa Gökhan ^d   Balci, Kevser Gülcihan ^d   Maden, Orhan ^a   Gürbü z, Oǧuz Alp ^e   Ardiç, Sadik ^c   Yeter, Ekrem ^d  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b Samsun Education and Research Hospital ^*  (Turkey)

^c Departments of Pulmonary Diseases   (Turkey)

^d Departments of Cardiology   (Turkey)

^e Diskapi Education and Research Hospital   (Turkey)

Author keywords

Adipocyte fatty acid binding protein; Echocardiography; Obstructive sleep apnea

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN 4;

ADULT; APNEA HYPOPNEA INDEX; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART PERFORMANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFORMANCE INDEX; OXYGEN SATURATION; PATIENT REFERRAL; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; AGE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY ASSESSMENT; PROTEIN BLOOD LEVEL;

ADULT; FATTY ACID-BINDING PROTEINS; FEMALE; HEART VENTRICLES; HUMANS; MALE; MYOCARDIUM; ORGAN SIZE; REGRESSION ANALYSIS; SLEEP APNEA, OBSTRUCTIVE;

EID: 85006137679     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31826868f2     Document Type: Article

References (44)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328: 1230-1235.
2. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest. 1988;94: 1200-1204.
3. Steiropoulos P, Kotsianidis I, Nena E, et al. Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep. 2009; 32:537-543.
4. Bravo Mde L, Serpero LD, Barceló A, et al. Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep Breath. 2007;11:177-185.
5. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129-1134.
6. Hertzel AV, Bernlohr DA. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab. 2000;11:175-180.
7. Boord JB, Fazio S, Linton MF. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol. 2002;13:141-147.
8. Boord JB, Maeda K, Makowski L, et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation. 2004;110:1492-1498.
9. Xu A, Wang Y, Xu JY, et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem. 2006;52:405-413.
10. Xu A, Tso AW, Cheung BM, et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation. 2007;115:1537-1543.
11. Tso AW, Xu A, Sham PC, et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care. 2007;30:2667-2672.
12. Makowski L, Boord JB, Maeda K, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 2001;7:699-705.
13. Yoo HJ, Kim S, Park MS, et al. Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. J Clin Endocrinol Metab. 2011;963:488-492.
14. Lam DC, Xu A, Lam KS, et al. Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance. Eur Respir J. 2009;33:346-351.
15. Lamounier-Zepter V, Look C, Alvarez J, et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res. 2009;105:326-334.
16. Xu A, Vanhoutte PM. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2012;302:H1231YH1240.
17. Mallampati SR, Gatt SP, Gugino LD, et al. A clinical sign to predict difficult tracheal intubation: a prospective study. Can Anaesth Soc J. 1985;32:429-434.
18. Song MK, Ha JH, Ryu SH, et al. The effect of aging and severity of sleep apnea on heart rate variability indices in obstructive sleep apnea syndrome. Psychiatry Investig. 2012;9:65-72.
19. Ozkan Y, Firat H, Simşek B, et al. Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath. 2008;12:149-154.
20. Schiller NB, Shah PM, Crawford M, et al. American Society of Echocardiography Committee on standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
21. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 1981;65:99-108.
22. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol. 1995;26:135-136.
23. Bruch C, Schmermund A, Marin D, et al. Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J. 2000;21:1888-1895.
24. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med. 2001;164:2147-2165.
25. Phillips B. Sleep-disordered breathing and cardiovascular disease. Sleep Med Rev. 2005;9:131-140.
26. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-1053.
27. Gozal D, Kheirandish L. Oxidant stress and inflammation in the snoring child: confluent pathways to upper airway pathogenesis and end-organ morbidity. Sleep Med Rev. 2006;10:83-96.
28. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003;290: 1906-1914.
29. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005;112:2660-2667.
30. Uysal KT, Scheja L, Wiesbrock SM, et al. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology. 2000;141:3388-3396.
31. Fu Y, Luo N, Lopes-Virella MF. Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in humanTHP-1 macrophages. J Lipid Res. 2000;41:2017-2023.
32. Kazemi MR, McDonald CM, Shigenaga JK, et al. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol. 2005;25:1220-1224.
33. Hui X, Li H, Zhou Z, et al. Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J Biol Chem. 2010;285:10273-10280.
34. Acioľu E, Yiǐt O, Volkan Sunter A, et al. Obesity and obstructive sleep apnea syndrome. J Otolaryngol Head Neck Surg. 2010; 39:744-751.
35. Shivalkar B, Van de Heyning C, Kerremans M, et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol. 2006;47:1433-1439.
36. Akar Bayram N, Ciftci B, Durmaz T, et al. Effects of continuous positive airway pressure therapy on left ventricular function assessed by tissue Doppler imaging in patients with obstructive sleep apnoea syndrome. Eur J Echocardiogr. 2009;10:376-382.
37. Dursunoglu D, Dursunoglu N, Evrengul H, et al. Impact of obstructive sleep apnoea on left ventricular mass and global function. Eur Respir J. 2005;26:283-288.
38. Makowski L, Brittingham KC, Reynolds JM, et al. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor F and IJB kinase activities. J Biol Chem. 2005;280:12888-12895.
39. Miyoshi T, Doi M, Hirohata S, et al. Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients. Heart Vessels. 2011;26:408-413.
40. Guillemin K, Krasnow MA. The hypoxic response: huffing and HIFing. Cell. 1997;89:9-12.
41. Imagawa S, Yamaguchi Y, Higuchi M, et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apneahypopnea syndrome. Blood. 2001;98:1255-1257.
42. Schulz R, Hummel C, Heinemann S, et al. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med. 2002;165:67-70.
43. Matsui H, Ihara Y, Fujio Y, et al. Induction of IL-6 by hypoxia is mediated by NF-kB and NF-IL-6 in cardiac myocyte. Cardiovasc Res. 1999;42:104-112.
44. Biron-Shental T, Schaiff WT, Ratajczak CK, et al. Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol. 2007;197:516.